Portland, OR (PRWEB) March 9, 2007
Innovation Asset Group, a leading provider of web-based enterprise applications for improving the management of intellectual assets and contracts, today announced that it has joined the Oregon Bioscience Association (OBA). Decipher empowers biotechnology, pharmaceutical and medical device companies to maximize the value of their intellectual assets including patents, trademarks, R&D, copyrights and related commitments.
"Interest in Decipher has intensified," said Shawn Pilkington, VP of Business Development at Innovation Asset. "The majority of the value in early- to mid-stage biotech organizations is contained in their intellectual property (IP); therefore, these assets must be strategically managed. We provide an enterprise application suite that allows companies to identify, organize and commercialize all the value of their IP while managing the real risks associated with compliance and disclosure." Decipher is helping companies including LI-COR Biosciences, DiagnoCure and Revivicor to achieve the full competitive advantage and commercialization potential of their IP.
"We're very pleased that Innovation Asset has joined the OBA. We have created a strong membership base, and we're seeing a high level of interest and dedication to helping Oregon-based bioscience industries achieve success and recognition," said Bob Lanier, OBA Executive Director. "With the high rate of innovation in these organizations, it is critical that there is an IP management strategy that aligns with their overall organizational goals," said Lanier. The OBA is a non-profit organization dedicated to promoting the growth and quality of the bioscience industry in Oregon, and helping the membership community to achieve their full economic and social potential. "In joining the OBA, Innovation Asset is dedicated to addressing the needs of the network of companies and experts in the Oregon community and the Pacific Northwest who are setting the pace in biotechnology, and who are taking their ideas from invention to commercialization," said Pilkington.
Decipher is a powerful information management system that delivers an ongoing, holistic view of the entire IP portfolio including patents, copyrights, license agreements, trademarks, invention disclosures and more. With sophisticated search tools, advance notifications, and real-time visibility, biotechnology firms are empowered to proactively manage all their IP down to the smallest detail in order to capitalize on opportunities, stay on top of their commitments and reduce risk. Decipher is available to enterprises either as an on-demand solution hosted by Innovation Asset or installed on internal company servers.
About Innovation Asset Group
Innovation Asset empowers companies to reveal hidden value by optimizing their intellectual assets, key contracts and commitments. Founded in 2002, the core team consists of experts in law, IP valuation, finance, and technology. Few companies have effective systems in place to maximize the commercial potential of their patents, trademarks, copyrights, and trade secrets and control their contracts and agreements. Innovation Asset was formed to address this problem. The company's flagship product, Decipher, is a web-based application suite for managing IP and contracts with advanced visualization, tracking, monitoring and security capabilities. For the latest news and information about the company, visit http://www.innovation-asset.com.
Decipher is a trademark of Innovation Asset Group, Inc. All other trademarks are property of their respective owners. © 2007 Innovation Asset Group, Inc. All rights reserved
Media and Analyst Contact:
Shayla B. Sharp
Innovation Asset Group, Inc.
# # #